Australians who have recovered from COVID-19 are being called on by researchers to help unravel the mystery of why people respond so differently to the virus.
Australia’s response to the COVID pandemic has been a spectacular success, but has come at significant economic and broader health costs. To avoid another surge in case numbers, it is crucial that we plan for the coming months as we head into 2021.
How hopeful should Australians and New Zealanders be about COVID-19 vaccines becoming available in 2021? And what do we need to learn from 2020 and this pandemic as we speed towards the new year?
Can we really expect our lives to go back to normal in a post-vaccine world? Professor Ian Frazer and Dr Kirsty Short are back to answer the COVID-19 questions on all of our minds.
An international team has found a way to potentially prevent the novel coronavirus from infecting cells, as well as clues as to why it is more infectious than similar viruses.
Federal funding will help a team of researchers determine how long immunity lasts in people who’ve recovered from COVID-19, critical information as the world waits for a vaccine.
Global biotech company CSL Limited will supply the Australian Government with 51 million doses of The University of Queensland’s COVID-19 vaccine candidate if it proves successful, under a heads of agreement announced today.
Pre-clinical testing of The University of Queensland’s COVID-19 vaccine has produced positive indications about its potential effectiveness and manufacturability.